Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MAGEA3 Antibody, Biotin conjugated

Product Specifications

CAS Number

9007-83-4

Gene Aliases

Antigen MZ2 D , Antigen MZ2-D, Cancer/testis antigen 1.3, Cancer/testis antigen family 1 member 3, CT1.3, HIP8, HYPD, MAGA3_HUMAN, MAGE 3 antigen, MAGE family member A3, MAGE-3 antigen, MAGE3, MAGEA3, MAGEA6, Melanoma antigen family A 3, Melanoma associated antigen 3, Melanoma-associated antigen 3, MGC1461

UniProt

P43357

Host

Rabbit

Antigen Species

Human

Reactivity

Human

Target Antigen

Recombinant Human Melanoma-associated antigen 3 protein (2-104AA)

Target

MAGEA3

Clonality

Polyclonal

Conjugation

Biotin

Applications

ELISA

Field of Research

Tags & Cell Markers

Purification Method

>95%, Protein G purified

Form

Liquid

Buffer

0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4.

Storage Conditions

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Fragment

IgG

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Anti-NAALADL1 Antibody, Rabbit Monoclonal
MBS8112172-01 0.1 mL

Recombinant Anti-NAALADL1 Antibody, Rabbit Monoclonal

Ask
View Details
Recombinant Anti-NAALADL1 Antibody, Rabbit Monoclonal
MBS8112172-02 5x 0.1 mL

Recombinant Anti-NAALADL1 Antibody, Rabbit Monoclonal

Ask
View Details
PPP1R1A Rabbit mAb
RDSA66977 100 µL

PPP1R1A Rabbit mAb

Ask
View Details
GIPC2 (GIPC PDZ Domain Containing Family, Member 2, FLJ20075, SEMCAP-2, SEMCAP2) (MaxLight 490)
MBS6206432-01 0.1 mL

GIPC2 (GIPC PDZ Domain Containing Family, Member 2, FLJ20075, SEMCAP-2, SEMCAP2) (MaxLight 490)

Ask
View Details
GIPC2 (GIPC PDZ Domain Containing Family, Member 2, FLJ20075, SEMCAP-2, SEMCAP2) (MaxLight 490)
MBS6206432-02 5x 0.1 mL

GIPC2 (GIPC PDZ Domain Containing Family, Member 2, FLJ20075, SEMCAP-2, SEMCAP2) (MaxLight 490)

Ask
View Details
EG245174 (m) -PR
sc-143398-PR 10 µM - 20 µL

EG245174 (m) -PR

Ask
View Details